623Wire StoriesTakeda Announces China NMPA Approval of LIVTENCITY® (maribavir) for the Treatment of Adults With Post-transplant Cytomegalovirus (CMV) Refractory to Prior Therapies
– LIVTENCITY Is the First and Only Inhibitor of CMV-specific UL97 Protein Kinase Approved in China for the Treatment of Adults With...
- 515Wire Stories
Scotland: TotalEnergies Farms Down 25.5% of the Seagreen Offshore Wind Farm to PTTEP
PARIS–(BUSINESS WIRE)–Regulatory News: TotalEnergies (Paris:TTE) (LSE:TTE) (NYSE:TTE): In line with its renewables business model, TotalEnergies has signed an agreement with Thailand’s national oil...
- 486Wire Stories
5G Market Evolution Report: Highlighting Investment Surge in Asia-Pacific and Emerging 6G Technologies – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Evolution of the World 5G Market: Investment, Spectrum and Next Steps” report has been added to ResearchAndMarkets.com’s offering. The telecommunications...
- 519News
The top 7 Best Places to Work in Romania for 2023 revealed
BUCHAREST, ROMANIA – Media OutReach Newswire – 21 December 2023 – McDonald’s Romania, Rebeldot, Pluxee, MSD, Arctic, Faptic Technology and First Bank...
- 503Wire Stories
AM Best Assigns Credit Ratings to Berking Re Limited
HONG KONG–(BUSINESS WIRE)–#insurance—AM Best has assigned the Financial Strength Rating of B (Fair) and the Long-Term Issuer Credit Rating of “bb+ (Fair)...
- 442Wire Stories
Vitol Enhances Compliance Monitoring With the Implementation of Behavox Quantum
NEW YORK–(BUSINESS WIRE)–Behavox announced today that Vitol, a global energy and commodities company, has successfully implemented Behavox’s Quantum AI SaaS solution. Behavox...
- 567Wire Stories
Monomoy Capital Partners to Acquire Leading Global Iron Casting Supplier Waupaca Foundry
WAUPACA, Wis. & NEW YORK & TOKYO–(BUSINESS WIRE)–Proterial, Ltd. (“Proterialâ€), a leading international producer of high-performance materials for mobility, industrial infrastructure, and...
- 523Wire Stories
ImmunoScape Partners with Singapore’s Experimental Drug Development Centre to Develop Novel T Cell Receptor-Based Therapeutics
The collaboration seeks to produce novel off-the-shelf TCR-based bispecific molecules designed to overcome current limitations in cell therapy approaches against solid tumors...
- 417Wire Stories
Valaris Takes Delivery of Newbuild Drillships VALARIS DS-13 and DS-14
HAMILTON, Bermuda–(BUSINESS WIRE)–Valaris Limited (NYSE: VAL) (“Valaris†or the “Companyâ€) announced today that it has exercised its options and taken delivery of...
- 509Wire Stories
New Passive Funds tracking Nifty Indices launched in Japan and Korea
7 new Passive Funds launched in 2023 MUMBAI, India–(BUSINESS WIRE)–#AUM–In the calendar year 2023, seven new Passive funds (ETFs/Index Funds) tracking Nifty...
